Simulation and matching-based approaches for indirect comparison of treatments

Related Experiment Video

Updated: Apr 16, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K

K Jack Ishak1, Irina Proskorovsky, Agnes Benedict

  • 1Evidera, Suite 500, 7575 Trans-Canada Highway, St-Laurent, QC, H4T 1V6, Canada, jack.ishak@evidera.com.

Pharmacoeconomics
|March 22, 2015
PubMed

Insights

Estimating relative treatment effects often requires indirect comparisons due to a lack of head-to-head trials. Advanced methods like simulated treatment comparison and matching-adjusted indirect comparison address challenges from heterogeneous studies and confounding factors.

Area of Science:

  • Health Economics
  • Biostatistics
  • Clinical Epidemiology

Background:

  • Head-to-head trials comparing treatments are infrequent, necessitating indirect comparisons.
  • Indirect treatment comparisons rely on networks of studies with common comparators.
  • Heterogeneity and multiple intermediate comparisons can reduce the reliability of indirect comparisons.

Purpose of the Study:

  • To provide an overview of advanced indirect comparison methods.
  • To discuss the application and utility of simulated treatment comparison (STC) and matching-adjusted indirect comparison (MAIC).
  • To explore how these methods can complement or serve as alternatives to standard meta-analysis techniques.

Main Methods:

  • Utilizes patient-level data for an index treatment and published data for a comparator treatment.
  • Accounts for population differences to mitigate confounding.
  • Employs simulated treatment comparison and matching-adjusted indirect comparison techniques.

Main Results:

  • STC and MAIC offer robust approaches for indirect treatment comparisons.
  • These methods can improve the reliability of effect estimates when direct comparisons are unavailable.
  • The paper outlines the conditions under which these advanced methods are most effective.

Conclusions:

  • Simulated treatment comparison and matching-adjusted indirect comparison are valuable tools for estimating relative treatment effects.
  • These methods enhance the ability to conduct reliable indirect comparisons, even with heterogeneous study data.
  • They serve as important alternatives or complements to traditional meta-analysis approaches in evidence synthesis.

More Related Videos

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.5K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
396
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
725
Sign Test for Matched Pairs01:17

Sign Test for Matched Pairs

The sign test for matched pairs offers a robust method for comparing two paired samples, often for the effects of an intervention in one of them. This method is very useful in situations where the underlying distribution of the data is unknown. The test compares two related samples—often pre- and post-treatment measurements on the same subjects—to determine if there are significant differences in their median values.
To conduct the sign test, we first calculate the differences in...
480
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
387
Multiple Comparison Tests01:13

Multiple Comparison Tests

Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
4.7K
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
219